CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/HCV-coinfected patients with advanced liver disease
DOI 10.1055/s-0036-1584038
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Mandorfer, P Schwabl, S Steiner, D Chromy, T Bucsics, AF Stättermayer, MC Aichelburg, K Grabmeier-Pfistershammer, M Trauner, T Reiberger, M Peck-Radosavljevic
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aim: We aimed to investigate the safety and efficacy of interferon (IFN)- and ribavirin (RBV)-free therapy with of sofosbuvir plus daclatasvir (SOF/DCV) in HIV/HCV-coinfected patients (HIV/HCV), who have an urgent need for effective antiviral therapy. We also assessed its impact on liver stiffness. Methods: Thirty-one thoroughly documented HIV/HCV with advanced liver disease (advanced liver fibrosis and/or portal hy…
Zitieren
Zitierempfehlung
M Mandorfer, P Schwabl, S Steiner, D Chromy, T Bucsics, AF Stättermayer, MC Aichelburg, K Grabmeier-Pfistershammer, M Trauner, T Reiberger, M Peck-Radosavljevic (2016) Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/HCV-coinfected patients with advanced liver disease. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0036-1584038
Mit CareLit weiterarbeiten